{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"authorship_tag":"ABX9TyPsmcON/NLdIzFdGuTQobtM"},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"}},"cells":[{"cell_type":"code","metadata":{"colab":{"resources":{"http://localhost:8080/nbextensions/google.colab/files.js":{"data":"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","ok":true,"headers":[["content-type","application/javascript"]],"status":200,"status_text":""}},"base_uri":"https://localhost:8080/","height":72},"id":"OacVjU9nAMJf","executionInfo":{"status":"ok","timestamp":1637523473569,"user_tz":360,"elapsed":6896,"user":{"displayName":"Manju Dash","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GheP2w8qHfQxno5e8BkFOF5WTG-iZbQMLrG9Sah7w=s64","userId":"03845859497458587034"}},"outputId":"0cd4d00b-72f0-4af3-b355-83807e6246a5"},"source":["from google.colab import files\n","uploaded_files= files.upload()"],"execution_count":null,"outputs":[{"output_type":"display_data","data":{"text/html":["\n","     <input type=\"file\" id=\"files-35d09a5c-35e7-4625-a0fd-bb8f32dfdc52\" name=\"files[]\" multiple disabled\n","        style=\"border:none\" />\n","     <output id=\"result-35d09a5c-35e7-4625-a0fd-bb8f32dfdc52\">\n","      Upload widget is only available when the cell has been executed in the\n","      current browser session. Please rerun this cell to enable.\n","      </output>\n","      <script src=\"/nbextensions/google.colab/files.js\"></script> "],"text/plain":["<IPython.core.display.HTML object>"]},"metadata":{}},{"output_type":"stream","name":"stdout","text":["Saving file_data.csv to file_data.csv\n"]}]},{"cell_type":"code","metadata":{"id":"5KTiTEBpr-r_"},"source":["import matplotlib.pyplot as plt\n","import numpy as np\n","import pandas as pd\n","import seaborn as sns\n","import io\n","# Make NumPy printouts easier to read.\n","np.set_printoptions(precision=3, suppress=True)"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"DOqusyVUscqe","executionInfo":{"status":"ok","timestamp":1637530505807,"user_tz":360,"elapsed":121,"user":{"displayName":"Manju Dash","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GheP2w8qHfQxno5e8BkFOF5WTG-iZbQMLrG9Sah7w=s64","userId":"03845859497458587034"}},"outputId":"0671af41-349b-404a-aadd-7152b468065d"},"source":["import tensorflow as tf\n","\n","from tensorflow import keras\n","from tensorflow.keras import layers\n","\n","print(tf.__version__)"],"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["2.7.0\n"]}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"vc0MMtQ-6oJZ","executionInfo":{"status":"ok","timestamp":1637530519644,"user_tz":360,"elapsed":260,"user":{"displayName":"Manju Dash","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GheP2w8qHfQxno5e8BkFOF5WTG-iZbQMLrG9Sah7w=s64","userId":"03845859497458587034"}},"outputId":"24c378c8-8aff-48d8-d884-cb11dfe72886"},"source":["#clinic_data = pd.read_csv(io.BytesIO(uploaded_files['file_data.csv']))\n","raw_dataset = pd.read_csv(io.BytesIO(uploaded_files['file_data.csv']), names=column_names,na_values='?', comment='\\t',sep=' ', skipinitialspace=True)\n","column_names = clinic_data.columns\n","print(raw_dataset)"],"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Salient Feature  ... Year founded\n","Salient                                            Feature,Ease                                       of                                                 clinical                            integration                           (1-4           :                   easiest),Sectors         of                         Healthcare               Affected            (1-4                       :                         many),Key                                  Customers,Robustness        of                                    underlying                                         technology                              (1-4                      :           robust),Underlying         'AI',Patient               Facing            Strength (1-4   :       highly                   visible),E                :          Access to  Proprietary   Data (1-4 :   difficult to  access),T/L :    Transformation and Loading  (1-4 :     stated goal),First Mover Advantage (1-4 :    first               on  ...      founded\n","Nuance,4,4,providers,2,,1,2,1,4,1,4,First          mover                                              advantage                                          +                                   extremely                             easy           to                  clinically               intergrate                 +                        able                to                         rapidly                   show                                       value,\"19,700.00\",1,1974    NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Change                                             Healthcare,2,2,4,1,,2,1,1,2,2,2,,\"13,000.00\",1,... NaN                                                NaN                                 NaN                                   NaN            NaN                 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Tempus                                             ,1,1,3,4,,1,4,4,3,3,1,\"Focusing                    on                                                 oncology                            datasets,                             lack           of                  market                   dilution,                  buidling                 proprietary         dataset                    in                        a                                          field                       that                                  is                                                 growing\",\"8,100.00\",1,2015              NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Datavant,2,4,2,1,,1,3,3,3,4,3,,\"7,000.00\",1,2017   NaN                                                NaN                                                NaN                                 NaN                                   NaN            NaN                 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","IQVIA,2,2,1,1,,1,3,3,4,2,2,\"Relatively             older                                              company                                            with                                market                                weight,        has                 likely                   built                      up                       proprietary         datasets                   and                       methods                                    that                        have                                  a                                                  proven                                  track                     record      for                        success\",\"5,156.00\",1,2016 NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Noom,4,1,consumers,1,,4,2,1,3,1,4,\"Heavy           marketing,                                         patient                                            facing                              application,                          low            barrier             to                       entry,                     real                     time                coaching                   +                         first                                      mover                       advantage\",\"4,240.00\",1,2006          NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Olive                                              AI,2,2,,2,,1,1,1,3,3,3,\"Focus                      on                                                 administrative                      overload                              reduction      +some               experience               in                         ML,                      specific            public                     use                       cases                                      +                           partnerships\",\"3,990.00\",1,2012       NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Zymergen,1,1,,2,N/A,1,1,1,1,3,1,\"Very              little                                             public                                             facing                              information,                          but            potential           to                       create                     biomanufacturing         for                 a                          wide                      range                                      of                          applications.                         Difficult                                          to                                      showcase                  value       quickly.                   ,3,036.17\",1,2013          NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Recursion,1,1,\"FDA,                                payers\",2,N/A,1,1,1,2,4,1,\"Automating              drug                                               development,                        diffifcult                            to             showcase            value                    quickly\",\"2,748.37\",1,2013 NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Insitro,1,1,\"FDA,                                  payers\",2,Seemingly                                language                                           models.                             Founder                               discusses      technology          that                     is                         almost                   universally         helped                     by                        large                                      complex                     language                              models                                             ,1,1,1,3,4,1,\"Using                     ML                        to          discover                   new                        drugs.            Founder  has    a       lot                      of                        experience in     ML  applications, but  they are focusing  on  diseases    with low            N   numbers, and  might have   to          rely  on        high drug prices              to  ...          NaN\n","Neuralink,3,3,\"consumers,                          healthcare                                         systems\",3,\"N/A,                                   likely                              proprietary\",4,1,1,4,3,4,\"May         not            need                clinical                 trials                     to                       show                value,                     only                      that                                       certain                     use                                   case                                               scenarios                               may                       be          helpful                    (e.g.                      consumer/prosumer device)  in     face    value\",\"2,105.00\",1,2016 NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","XtalPi,1,1,\"FDA,                                   payers\",3,N/A,1,1,1,3,4,1,AI'                      drug                                               discovery                           but                                   no             outward             facing                   details.                   ,\"2,006.42\",1,2014       NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Innovaccer,1,2,Employers,2,N/A,2,3,4,2,4,4,ETL     of                                                 healthcare                                         data                                +                                     real           time                analytics                teams                      +                        interoperability.   Did                        not                       see                                        any                         'AI'                                  capability                                         though,\"1,300.00\",1,2014                NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Freenome,1,1,consumers,3,N/A,1,3,1,3,4,1,Deep      learning                                           to                                                 find                                biomarkers                            for            detection.          Uphill                   battle                     for                      regulatory          approval,\"1,120.00\",1,2014 NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Accolate,4,1,healthcare                            systems,2,N/A,4,1,1,3,1,3,Able                     to                                                 showcase                            value                                 quickly        by                  offering                 medical                    services                 +                   healthcare                 suppor                    to                                         employees,\"1,040.28\",1,2007 NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","PathAI,2,3,\"FDA,                                   payers\",3,\"\"\"deep                                  learning\"\"\",1,3,2,4,4,4,\"Use                       image                               analytics                             to             show                power                    of                         deep                     learning            for                        pathology                 images,                                    now                         pivoting                              to                                                 clinical                                trials\",\"1,015.00\",1,2016 NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Evidation                                          Health,3,3,Employers,3,\"\"\"machine                  learning\"\"\",3,4,3,4,3,4,\"Low                       regulatory                          difficulty                            coupled        with                innovative               datastream,                access                   to                  proprietary                data                      +                                          publications                re:                                   outcomes\",\"1,003.00\",1,2012                        NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Immunai,1,2,healthcare                             systems,3,CNN,1,2,1,2,3,1,\"Proven                  track                                              record                              from                                  academic       lab,                with                     publications               but                      many                steps                      required                  to                                         operationalize              their                                 work\",\"1,000.00\",1,2018                            NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","nference,2,4,\"consumers,                           healthcare                                         systems,                                           employers\",4,N/A,2,4,3,4,4,4,\"Large partnership                           with           mayo,               also,                    their                      partnership              is                  exclusive\",861.00,1,2013   NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","OM1,2,4,academic                                   /                                                  industry                                           researchers,4,CNN,1,3,4,2,4,4,\"Able to                                    showcase       value               through                  descriptive                analytics                and                 access                     to                        large                                      clinical                    registries,                           databases                                          that                                    may                       be          proprietary\",855.00,1,2015 NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Twin,3,1,healthcare                                systems,2,language                                 models,4,1,1,2,1,3,Able                            to                                  showcase                              value          but                 their                    claims                     are                      too                 lofty                      to                        be                                         reasonably                  persuasive,840.00,1,2018              NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Finch                                              (drug                                              discovery),3,1,healthcare                          systems,3,N/A,2,1,1,2,4,4,Currently focusing                              on             a                   very                     narrow                     indication               that                might                      be                        benefited                                  by                          a                                     microbiome                                         reset.                                  Will                      have        to                         charge                     high              cost     to     justify ,801.47,1,2014           NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Mindstrong,4,1,consumers,1,N/A,3,1,1,2,3,4,On      demand                                             mental                                             health                              services                              billed         through             insurance                companies,675.00,1,2014    NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Viz.ai,2,1,\"consumers,                             payers\",4,None,1,4,1,4,4,4,Able                    to                                                 narrow                              scope                                 enough         for                 a                        high                       risk                     indication          to                         showcase                  value                                      immediately,641.00,1,2016   NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Notable,2,1,\"consumers,                            payers\",3,None,1,1,1,3,2,4,Automating              administrative                                     tasks                               to                                    show           value,628.00,1,2017 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Welltok,2,1,\"consumers,                            payers\",2,None,4,2,1,2,2,3,Minimizing              the                                                gap                                 between                               employees      and                 HR,625.00,1,2009         NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Paige,2,1,\"providers,                              payers\",4,CNN,1,3,1,3,4,4,Digital                  pathology                                          tooks                               to                                    improve        provider            efficiency,575.00,1,2017 NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Mojo                                               Vision,4,1,\"providers,                             payers\",4,None,3,1,1,4,4,4,\"Consumer               product,                            needs                                 regulatory     approval            but                      if                         approved,                will                be                         first                     in                                         its                         kind                                  ,501.00,1,2015\\r\\nDyno Therapeutics,1,1,consumers, employers\",4,None,1,1,1,4,4,2,Difficult to                        showcase    value                      given                      long              time     frames for     drug                     development,500.00,1,2018 NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Juvenescence                                       ,4,1,providers,2,CNN,1,1,1,1,1,3,They              make                                               one                                 product?                              ,500.00,1,2016 NaN                 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Taysha                                             Gene                                               Therapies,3,1,consumers,3,N/A,1,1,1,4,3,3,Diffi... to                                  showcase                              value          given               long                     time                       frames                   for                 drug                       development,500.00,1,2019 NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Valo,3,1,biotech                                   firms,3,PCA,1,3,1,3,3,2,Able                       to                                                 show                                knowledge                             of             regulatory          affairs                  but                        interesting              ,500.00,1,2019      NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Clarify,3,4,consumers,2,None,3,2,1,4,3,3,,450.0... NaN                                                NaN                                                NaN                                 NaN                                   NaN            NaN                 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Synthego,1,1,\"consumers,                           providers\",3,None,2,1,1,2,4,2,Difficult            to                                                 show                                value                                 in             long                term                     without                    any                      viable              products,450.00,1,2012     NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Atomwise,1,1,\"consumers,                           payers\",3,N/A,2,2,2,2,4,3,Using                    a                                                  CNN                                 (off                                  the            shelf)              approach                 and                        integrating              it.                 ,423.00,1,2012             NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Suki,3,4,consumers,2,None,1,1,1,1,1,4,Can          showcase                                           value                                              quickly                             but                                   needs          to                  overtake                 nuance,400.00,0,2016       NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Benchling,1,1,\"payers,                             providers\",3,N/A,1,3,4,3,3,4,Mostly                descriptive                                        analytics                           built                                 on             top                 of                       ETL                        engine                   for                 life                       sciences                  research,311.80,0,2012                     NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Komodo                                             Health,1,3,drug                                    companies,2,CNN,1,3,4,3,4,4,Descriptive            analytics                           built                                 off            ETL'ed              healthcare               data,327.50,0,2014         NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Cedar,4,4,\"providers,                              healthcare                                         systems\",1,N/A,4,1,1,2,1,4,\"Can                    show                                case                                  value          through             easy                     payment,                   easy                     to                  take                       over\",350.81,0,2016       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Unite                                              Us,2,2,consumers,1,None,2,2,1,3,2,2,Difficult      to                                                 show                                value,195.30,0,2013                   NaN            NaN                 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Curology,4,2,\"payers,                              employers\",1,None,4,1,1,2,1,4,On                   demand                                             skin                                care                                  &              consultation        services,61.65,0,2014    NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","PatientPop,2,4,researchers,1,None,1,3,1,3,1,4,\"Can showcase                                           value                                              quickly                             by                                    increasing     web                 presence,                SEO                        and                      demonstrating       higher                     traffic                   ,195.71,0,2014\\r\\nNexHealth,2,2,providers, healthcare                  systems\",2,N/A,1,1,1,2,2,4,Scheduling platform                                           /                                       +                         descriptive analytics,52.71,0,2017     NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Patientco                                          Holdings,4,3,\"healthcare                           systems,                                           payers,                             consumers\",1,None,2,1,1,2,2,4,Payment processor.     ,34.14,0,2009       NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Transcarent,3,3,\"consumers,                        employers,                                         payers\",2,None,4,1,1,3,3,4,\"Rapid                  access                              to                                    healthcare     through             any                      device,                    contracted               for                 low                        or                        zero                                       cost                        through                               payers\",104.29,0,2020                              NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Vida                                               Health,4,3,\"consumers,                             payers\",2,None,3,1,1,2,2,3,Treating                reasonable                          targets                               for            chronic             medical                  and                        wellness                 goals,195.00,0,2014 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Tendo                                              Systems,2,3,payers,1,None,2,1,1,1,4,3,,67.35,0,... NaN                                                NaN                                 NaN                                   NaN            NaN                 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Aetion,2,4,\"consumers,                             employers\",3,None,1,4,4,3,2,4,RWE                  similar                                            to                                  atropos,203.60,0,2013                 NaN            NaN                 NaN                      NaN                        NaN                      NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","Medable,2,1,\"employers,                            payers\",4,None,2,3,1,3,4,4,Rapid                   integration                                        of                                  digital                               services       for                 clinical                 trial                      management,195.71,0,2015 NaN                 NaN                        NaN                       NaN                                        NaN                         NaN                                   NaN                                                NaN                                     NaN                       NaN         NaN                        NaN                        NaN               NaN      NaN    NaN     NaN                      NaN                       NaN        NaN    NaN NaN           NaN  NaN  NaN NaN       NaN NaN         NaN  NaN            NaN NaN      NaN  NaN   NaN    NaN         NaN   NaN       NaN  NaN  NaN                NaN  ...          NaN\n","\n","[48 rows x 16 columns]\n"]}]},{"cell_type":"markdown","source":["# New Section"],"metadata":{"id":"O69qAJzPdRRC"}},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":309},"id":"Xa3vJrXWYjAK","executionInfo":{"status":"ok","timestamp":1637530516029,"user_tz":360,"elapsed":115,"user":{"displayName":"Manju Dash","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GheP2w8qHfQxno5e8BkFOF5WTG-iZbQMLrG9Sah7w=s64","userId":"03845859497458587034"}},"outputId":"80c4dc83-9913-42ee-94e3-7c2bd92e3fe6"},"source":["clinic_data = raw_dataset.copy()\n","clinic_data.tail()"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th>Salient Feature</th>\n","      <th>Ease of clinical integration (1-4 : easiest)</th>\n","      <th>Sectors of Healthcare Affected (1-4 : many)</th>\n","      <th>Key Customers</th>\n","      <th>Robustness of underlying technology (1-4 : robust)</th>\n","      <th>Underlying 'AI'</th>\n","      <th>Patient Facing Strength (1-4 : highly visible)</th>\n","      <th>E : Access to Proprietary Data (1-4 : difficult to access)</th>\n","      <th>T/L : Transformation and Loading (1-4 : stated goal)</th>\n","      <th>First Mover Advantage (1-4 : first on scene)</th>\n","      <th>Regulatory Difficulty (1-4 : high)</th>\n","      <th>Ability to showcase value (1 - 4: quickly)</th>\n","      <th>Proposed Secret?</th>\n","      <th>Valuation</th>\n","      <th>Binary Label</th>\n","      <th>Year founded</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>Transcarent,3,3,\"consumers,</th>\n","      <th>employers,</th>\n","      <th>payers\",2,None,4,1,1,3,3,4,\"Rapid</th>\n","      <th>access</th>\n","      <th>to</th>\n","      <th>healthcare</th>\n","      <th>through</th>\n","      <th>any</th>\n","      <th>device,</th>\n","      <th>contracted</th>\n","      <th>for</th>\n","      <th>low</th>\n","      <th>or</th>\n","      <th>zero</th>\n","      <th>cost</th>\n","      <th>through</th>\n","      <th>payers\",104.29,0,2020</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>Vida</th>\n","      <th>Health,4,3,\"consumers,</th>\n","      <th>payers\",2,None,3,1,1,2,2,3,Treating</th>\n","      <th>reasonable</th>\n","      <th>targets</th>\n","      <th>for</th>\n","      <th>chronic</th>\n","      <th>medical</th>\n","      <th>and</th>\n","      <th>wellness</th>\n","      <th>goals,195.00,0,2014</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>Tendo</th>\n","      <th>Systems,2,3,payers,1,None,2,1,1,1,4,3,,67.35,0,2020</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>Aetion,2,4,\"consumers,</th>\n","      <th>employers\",3,None,1,4,4,3,2,4,RWE</th>\n","      <th>similar</th>\n","      <th>to</th>\n","      <th>atropos,203.60,0,2013</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>Medable,2,1,\"employers,</th>\n","      <th>payers\",4,None,2,3,1,3,4,4,Rapid</th>\n","      <th>integration</th>\n","      <th>of</th>\n","      <th>digital</th>\n","      <th>services</th>\n","      <th>for</th>\n","      <th>clinical</th>\n","      <th>trial</th>\n","      <th>management,195.71,0,2015</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <th>NaN</th>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["                                                                                                                                                                                                                                                                                                                                                                                                                             Salient Feature  ... Year founded\n","Transcarent,3,3,\"consumers, employers,                                         payers\",2,None,4,1,1,3,3,4,\"Rapid   access     to                    healthcare through any      device, contracted               for                 low or  zero cost through payers\",104.29,0,2020 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN             NaN  ...          NaN\n","Vida                        Health,4,3,\"consumers,                             payers\",2,None,3,1,1,2,2,3,Treating reasonable targets               for        chronic medical  and     wellness                 goals,195.00,0,2014 NaN NaN NaN  NaN  NaN     NaN                   NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN             NaN  ...          NaN\n","Tendo                       Systems,2,3,payers,1,None,2,1,1,1,4,3,,67.35,0,... NaN                                 NaN        NaN                   NaN        NaN     NaN      NaN     NaN                      NaN                 NaN NaN NaN  NaN  NaN     NaN                   NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN             NaN  ...          NaN\n","Aetion,2,4,\"consumers,      employers\",3,None,1,4,4,3,2,4,RWE                  similar                             to         atropos,203.60,0,2013 NaN        NaN     NaN      NaN     NaN                      NaN                 NaN NaN NaN  NaN  NaN     NaN                   NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN             NaN  ...          NaN\n","Medable,2,1,\"employers,     payers\",4,None,2,3,1,3,4,4,Rapid                   integration                         of         digital               services   for     clinical trial   management,195.71,0,2015 NaN                 NaN NaN NaN  NaN  NaN     NaN                   NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN             NaN  ...          NaN\n","\n","[5 rows x 16 columns]"]},"metadata":{},"execution_count":37}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"Zyqj0DN9ZqF9","executionInfo":{"status":"ok","timestamp":1637530513662,"user_tz":360,"elapsed":160,"user":{"displayName":"Manju Dash","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GheP2w8qHfQxno5e8BkFOF5WTG-iZbQMLrG9Sah7w=s64","userId":"03845859497458587034"}},"outputId":"5acf950b-c190-4b26-82ed-001cf5155724"},"source":["clinic_data.isna().sum()"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["Salient Feature                                               0\n","Ease of clinical integration (1-4 : easiest)                  0\n","Sectors of Healthcare Affected (1-4 : many)                   0\n","Key Customers                                                 0\n","Robustness of underlying technology (1-4 : robust)            0\n","Underlying 'AI'                                               0\n","Patient Facing Strength (1-4 : highly visible)                0\n","E : Access to Proprietary Data (1-4 : difficult to access)    0\n","T/L : Transformation and Loading (1-4 : stated goal)          0\n","First Mover Advantage (1-4 : first on scene)                  0\n","Regulatory Difficulty (1-4 : high)                            0\n","Ability to showcase value (1 - 4: quickly)                    0\n","Proposed Secret?                                              0\n","Valuation                                                     0\n","Binary Label                                                  0\n","Year founded                                                  0\n","dtype: int64"]},"metadata":{},"execution_count":36}]},{"cell_type":"code","metadata":{"id":"Bl4VNFDJZ2zc","colab":{"base_uri":"https://localhost:8080/","height":156},"executionInfo":{"status":"error","timestamp":1727576146352,"user_tz":300,"elapsed":199,"user":{"displayName":"Manju Dash","userId":"03845859497458587034"}},"outputId":"52b471c4-d8b6-4b9b-af8e-0b5508a7e719"},"source":["clinic_data = clinic_data.dropna()\n","clinic_data.tail()"],"execution_count":1,"outputs":[{"output_type":"error","ename":"NameError","evalue":"name 'clinic_data' is not defined","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)","\u001b[0;32m<ipython-input-1-f98b38934140>\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mclinic_data\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mclinic_data\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdropna\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m \u001b[0mclinic_data\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtail\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mNameError\u001b[0m: name 'clinic_data' is not defined"]}]},{"cell_type":"code","metadata":{"id":"tobOMN1mbiMA"},"source":["train_dataset = clinic_data.sample(frac=0.8, random_state=0)\n","test_dataset = clinic_data.drop(train_dataset.index)"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":358},"id":"nxro7JQHbrMH","executionInfo":{"status":"error","timestamp":1637533578392,"user_tz":360,"elapsed":136,"user":{"displayName":"Manju Dash","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GheP2w8qHfQxno5e8BkFOF5WTG-iZbQMLrG9Sah7w=s64","userId":"03845859497458587034"}},"outputId":"79019a2e-bcb3-463a-bf9f-54cc912ee821"},"source":["sns.pairplot(train_dataset[['Ability to showcase value (1 - 4: quickly)', 'Year founded']], diag_kind='kde')"],"execution_count":null,"outputs":[{"output_type":"error","ename":"ValueError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mValueError\u001b[0m                                Traceback (most recent call last)","\u001b[0;32m<ipython-input-51-cefbfc73a650>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0msns\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mpairplot\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtrain_dataset\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'Ability to showcase value (1 - 4: quickly)'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'Year founded'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mdiag_kind\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m'kde'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m","\u001b[0;32m/usr/local/lib/python3.7/dist-packages/seaborn/_decorators.py\u001b[0m in \u001b[0;36minner_f\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m     44\u001b[0m             )\n\u001b[1;32m     45\u001b[0m         \u001b[0mkwargs\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mupdate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m{\u001b[0m\u001b[0mk\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0marg\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mk\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0marg\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mzip\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0msig\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mparameters\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0margs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m}\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 46\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mf\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     47\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0minner_f\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     48\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;32m/usr/local/lib/python3.7/dist-packages/seaborn/axisgrid.py\u001b[0m in \u001b[0;36mpairplot\u001b[0;34m(data, hue, hue_order, palette, vars, x_vars, y_vars, kind, diag_kind, markers, height, aspect, corner, dropna, plot_kws, diag_kws, grid_kws, size)\u001b[0m\n\u001b[1;32m   2096\u001b[0m     grid = PairGrid(data, vars=vars, x_vars=x_vars, y_vars=y_vars, hue=hue,\n\u001b[1;32m   2097\u001b[0m                     \u001b[0mhue_order\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mhue_order\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mpalette\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mpalette\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcorner\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mcorner\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2098\u001b[0;31m                     height=height, aspect=aspect, dropna=dropna, **grid_kws)\n\u001b[0m\u001b[1;32m   2099\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2100\u001b[0m     \u001b[0;31m# Add the markers here as PairGrid has figured out how many levels of the\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;32m/usr/local/lib/python3.7/dist-packages/seaborn/_decorators.py\u001b[0m in \u001b[0;36minner_f\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m     44\u001b[0m             )\n\u001b[1;32m     45\u001b[0m         \u001b[0mkwargs\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mupdate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m{\u001b[0m\u001b[0mk\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0marg\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mk\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0marg\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mzip\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0msig\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mparameters\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0margs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m}\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 46\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mf\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     47\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0minner_f\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     48\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;32m/usr/local/lib/python3.7/dist-packages/seaborn/axisgrid.py\u001b[0m in \u001b[0;36m__init__\u001b[0;34m(self, data, hue, hue_order, palette, hue_kws, vars, x_vars, y_vars, corner, diag_sharey, height, aspect, layout_pad, despine, dropna, size)\u001b[0m\n\u001b[1;32m   1231\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1232\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0mx_vars\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1233\u001b[0;31m             \u001b[0;32mraise\u001b[0m \u001b[0mValueError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"No variables found for grid columns.\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1234\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0my_vars\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1235\u001b[0m             \u001b[0;32mraise\u001b[0m \u001b[0mValueError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"No variables found for grid rows.\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mValueError\u001b[0m: No variables found for grid columns."]}]}]}